Answers are grounded in this paper and cite their sources.
Fibrolamellar carcinoma can be part of the Carney complex; in this setting, fibrolamellar carcinomas have inactivating PRKAR1A mutations instead of the DNAJB1-PRKACA fusion gene found in sporadic fibrolamellar carcinomas, providing an alternate means for activation of protein kinase A. (Hepatology 2017).
No takes yet. Share an insight, caveat, or question.
Graham et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: